111 related articles for article (PubMed ID: 453872)
1. Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of scleroderma.
Cormane RH; Hamerlinck F; Nunzi E
Arch Dermatol; 1979 Jun; 115(6):709-12. PubMed ID: 453872
[TBL] [Abstract][Full Text] [Related]
2. [Vascular lesions and fibroblast metabolism in inflammatory diseases].
Lapière CM
Phlebologie; 1987; 40(1):21-9. PubMed ID: 3575433
[TBL] [Abstract][Full Text] [Related]
3. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD1a and CD86 on scleroderma Langerhans cells.
Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
Fleischmajer R; Perlish JS; West WP
Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
[TBL] [Abstract][Full Text] [Related]
6. Vascular changes in morphea.
Kobayasi T; Serup J
Acta Derm Venereol; 1985; 65(2):116-20. PubMed ID: 2408412
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
[TBL] [Abstract][Full Text] [Related]
8. Localized scleroderma (morphoea). Clinical, physiological, biochemical and ultrastructural studies with particular reference to quantitation of scleroderma.
Serup J
Acta Derm Venereol Suppl (Stockh); 1986; 122():3-61. PubMed ID: 2939680
[No Abstract] [Full Text] [Related]
9. Guttate morphea in a scleroderma spectrum disorder patient with anticentromere antibody.
Yamanaka M; Ishikawa O
Eur J Dermatol; 2009; 19(6):630-1. PubMed ID: 19596641
[No Abstract] [Full Text] [Related]
10. Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine.
Fleischmajer R; Perlish JS; Shaw KV; Pirozzi DJ
Arch Dermatol; 1976 Nov; 112(11):1553-7. PubMed ID: 984860
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies in children with localized scleroderma.
Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
[TBL] [Abstract][Full Text] [Related]
12. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
Bell SA; Faust H; Mittermüller J; Kolb HJ; Meurer M
Br J Dermatol; 1996 May; 134(5):848-54. PubMed ID: 8736324
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.
Penning CA; Cunningham J; French MA; Harrison G; Rowell NR; Hughes P
Clin Exp Immunol; 1984 Sep; 57(3):548-56. PubMed ID: 6467679
[TBL] [Abstract][Full Text] [Related]
14. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
[TBL] [Abstract][Full Text] [Related]
15. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
16. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma.
Xie Y; Zhang X; Wakasugi S; Makino T; Inoue Y; Ihn H
Int J Dermatol; 2008 May; 47(5):438-42. PubMed ID: 18412858
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of the fibrosis in scleroderma skin.
Fleischmajer R; Perlish JS
Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
[No Abstract] [Full Text] [Related]
19. Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies.
Duijvestijn AM; Kerkhove M; Bargatze RF; Butcher EC
J Immunol; 1987 Feb; 138(3):713-9. PubMed ID: 3543117
[TBL] [Abstract][Full Text] [Related]
20. [Immunologic changes in linear scleroderma in children. Apropos of 11 cases].
Fontan I; Taïeb A; Guillet G; Rommel A; Fontan D; Maleville J
Ann Dermatol Venereol; 1988; 115(2):135-41. PubMed ID: 3293512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
